Bavarian Nordic A/S Stock price

Equities

BAVA

DK0015998017

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 11:59:33 2024-03-27 am EDT 5-day change 1st Jan Change
155 DKK -0.10% Intraday chart for Bavarian Nordic A/S -0.67% -12.68%
Sales 2024 * 5.18B 750M Sales 2025 * 4.99B 722M Capitalization 12.08B 1.75B
Net income 2024 * 646M 93.57M Net income 2025 * 855M 124M EV / Sales 2024 * 2.22 x
Net cash position 2024 * 569M 82.48M Net cash position 2025 * 861M 125M EV / Sales 2025 * 2.25 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
14.2 x
Employees 1,379
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.10%
1 week-0.67%
Current month-0.80%
1 month-6.54%
3 months-13.36%
6 months+0.32%
Current year-12.68%
More quotes
1 week
152.60
Extreme 152.6
159.00
1 month
147.95
Extreme 147.95
175.75
Current year
147.95
Extreme 147.95
182.50
1 year
125.55
Extreme 125.55
222.00
3 years
115.20
Extreme 115.2
411.00
5 years
103.20
Extreme 103.2
411.00
10 years
95.00
Extreme 95
444.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 98-12-31
Director of Finance/CFO 59 18-10-31
Chief Operating Officer 56 22-03-31
Members of the board TitleAgeSince
Director/Board Member 73 10-04-26
Director/Board Member 57 22-12-31
Director/Board Member 62 16-04-19
More insiders
Date Price Change Volume
24-03-27 155 -0.10% 193,997
24-03-26 155.1 +0.91% 379,123
24-03-25 153.7 -1.98% 337,427
24-03-22 156.8 -0.88% 569,062
24-03-21 158.2 +1.41% 377,171

Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT

More quotes
Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases. Net sales by revenue source are divided between sales of products (95.8%) and services (4.2%). Net sales are distributed geographically as follows: the United States (26.7%), Germany (20.6%), Belgium (10.6%), France (8.5%), Canada (6.3%), the United Kingdom (5.4%), Hong Kong (3.7%), Saudi Arabia (3.2%), Australia (3.1%), Switzerland (2.2%) and other (9.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
155 DKK
Average target price
276.8 DKK
Spread / Average Target
+78.64%
Consensus
  1. Stock
  2. Equities
  3. Stock Bavarian Nordic A/S - Nasdaq Copenhagen